D57.45

Clinical Causes: Inheritance of defective genes from both parents, specifically one sickle-cell gene and one beta plus thalassemia gene Autosomal recessive inheritance pattern Genetic mutations affecting hemoglobin production

Key Symptoms: Episodes of intense pain, often in the chest, abdomen, joints, or back Fatigue and weakness due to anemia Swelling in hands and feet (dactylitis) Frequent infections Delayed growth and puberty in children Jaundice or yellowing of the skin and eyes Shortness of breath Blurred vision

Diagnosis Path: Diagnosis involves a combination of blood tests and genetic evaluations. Typical procedures include: - Complete blood count (CBC): to assess anemia and abnormal cells - Hemoglobin electrophoresis: to identify abnormal hemoglobin variants - Blood smear microscopy: to visualize sickled cells - Genetic testing: to identify mutations associated with sickle-cell disease and thalassemia - Reticulocyte count: to assess red blood cell production These tests help confirm the diagnosis and determine the severity of the condition.

Treatment Protocols: Managing sickle-cell beta plus thalassemia with crisis aims to reduce symptoms, prevent complications, and improve quality of life. Treatment options include: - Pain management during crises using medications such as opioids and non-steroidal anti-inflammatory drugs (NSAIDs) - Hydroxyurea: a medication that can reduce the frequency of crises and the need for blood transfusions - Blood transfusions: to treat severe anemia and prevent stroke - Antibiotics and vaccines: to prevent infections - Folic acid supplements: to support red blood cell production - Bone marrow or stem cell transplantation: a potential cure in select cases - Regular monitoring by healthcare professionals for early detection of complications Lifestyle modifications, including adequate hydration and avoiding extreme temperatures, also play a role in managing symptoms.